Related Experiment Video

Updated: Mar 1, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

14.3K

[Immunotherapy of renal cell cancer]

Lajos Géczi1, Krisztián Nagyiványi1, Anikó Maráz2

  • 1Kemoterápia C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. gelajos@oncol.hu.

Magyar Onkologia
|June 7, 2017
PubMed

Insights

New kidney cancer immunotherapy strategies combine targeted therapy with checkpoint inhibitors (anti-CTLA-4, PD-1, PD-L1/2) and novel agents like pegylated interleukin-2, showing promise in clinical trials.

Area of Science:

  • Oncology
  • Immunotherapy
  • Nephrology

Background:

  • Kidney cancer, specifically metastatic clear cell renal carcinoma, presents treatment challenges.
  • Targeted therapy has shown efficacy, but new approaches are needed.
  • Immunotherapy offers a promising avenue for enhancing anti-tumor responses.

Purpose of the Study:

  • To review current targeted therapy outcomes in kidney cancer.
  • To present novel immunotherapy solutions for renal carcinoma.
  • To discuss the combination of targeted drugs and immunotherapy.

Main Methods:

  • Review of checkpoint inhibitors (anti-CTLA-4, PD-1, PD-L1/2) and their combinations.
  • Presentation of novel agents including pegylated interleukin-2 and cancer vaccines.
  • Analysis of key clinical trials (CheckMate-025, AGS-003, IMA 901) and ongoing Phase III trials.

Main Results:

  • Checkpoint inhibitors and their combinations demonstrate significant efficacy.
  • Combinations of targeted therapy with immunotherapy show enhanced outcomes.
  • Novel agents and vaccination strategies are emerging as promising treatments.

Conclusions:

  • Combination strategies integrating targeted therapy and immunotherapy represent the future of kidney cancer treatment.
  • Ongoing clinical trials are crucial for validating these novel approaches.
  • Advances in immunotherapy offer new hope for patients with metastatic renal carcinoma.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
572